<DOC>
	<DOCNO>NCT02679560</DOCNO>
	<brief_summary>This investigator-initiated , single-center , randomize , patient blind , control trial . The purpose study compare effect fascia iliaca compartment block ( FICB ) use 0.2 % ropivacaine vs. liposomal bupivacaine patient femur and/or hip fracture admit University California Davis Medical Center ( UCDMC ) . The primary endpoint total opioid requirement 72 hour randomization period secondary endpoint include total daily opioid requirement day 1-3 , duration effect objective pain score use numeric rating scale ( NRS ) hospital stay .</brief_summary>
	<brief_title>Effects Liposomal Bupivacaine Acute Pain Hip Femur Fractures</brief_title>
	<detailed_description>In patient femur hip fracture , fascia iliaca compartment block use liposomal bupivacaine result less total opioid administration randomization period compare fascia iliaca compartment block use 0.2 % ropivacaine . The long-term goal study provide pilot information guide design large , multicenter trial evaluate utility cost-effectiveness long act liposomal bupivacaine opioid-sparring analgesic strategy injured trauma patient . Ultimately , hop information improve safe effective narcotic spar analgesia awake , combat casualty , well serve primary step towards</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Femoral Fractures</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>1 . Patient 's s/p trauma , confirm femur and/or hip fracture plan admission hospital 2 . Patient ambulatory without assistance ( e.g . walker , cane , caretaker ) prior incident . 1 . &gt; 10 hour since presentation emergency department 2. central peripheral neurologic deficit presentation 3. concern compartment syndrome 4. associate additional long bone fracture 5. end stage liver failure 6. renal failure require dialysis 7. pregnancy breast feed 8. prisoner 9. coagulopathy internalize normal ratio ( INR ) &gt; 1.5 10. use direct thrombin inhibitor ( bivalirudin , argatroban , desirudindabigatran etexilate ) , direct factor Xa inhibitor ( rivaroxaban , apixaban , edoxaban ) 11. suspect prolonged intubation within first 12 hour secondary respiratory failure periprocedurally 12 . Adults unable consent 13 . Pediatric patient &lt; 18 year old 14 . Patients exhibit sign shock upon admission , heart rate ( HR ) &gt; 120 systolic blood pressure ( SBP ) &lt; 100 mmHg . 15 . History allergic reaction local anesthetic 16 . Administration local anesthetic 2 hour prior study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>femur fracture , hip fracture , exparel , liposomal bupivacaine</keyword>
</DOC>